Skip to content


Pharmacokinetics and Modeling Lab

The PK Lab supports clinical studies through the analysis of drugs in an array of biological matrices (e.g. plasma, urine, lymphocytes), along with analysis and modeling of pharmacokinetic-pharmacodynamic (PK-PD) data. The PK Lab also has the capability to conduct various studies for the in vitro characterization of drug metabolism and transport.
Learn More

Targeted Long-Acting Combination Antiretroviral Therapy Program (TLC-ART)

We are scientists and physicians working toward developing a long acting and effective treatment to improve patient compliance and therapeutic outcomes. We hope to maximally suppress HIV and potentially contribute to a cure for AIDS.
Learn More

Program on Pharmacokinetics of Drugs of Abuse during Pregnancy (UWPKDAP)

The primary purpose of the program is to elucidate the fundamental mechanisms of maternal-fetal drug disposition in pregnant women with special emphasis on drugs of abuse, treatment of drug abuse.
Learn More

The Washington Entrepreneurial Research Evaluation and Commercialization Hub (WE-REACH)

The Washington Entrepreneurial Research Evaluation and Commercialization Hub (WE-REACH) is a public/private partnership designed to facilitate and accelerate the transformation of regional health research innovations into market ready products and services that impact health outcomes.
Learn More